Cadila's Q4 profit up 53.59% to Rs 262.46 cr

Drug maker Cadila Healthcare today reported 53.59% rise in consolidated net profit at Rs 262.46 crore for the fourth quarter ended March 31.

The company had posted a consolidated net profit of Rs 170.88 crore in same quarter of the previous fiscal, the company said in a filing to the BSE.

Total consolidated income during the quarter under review was Rs 1,620.63 crore as against Rs 1,413.38 crore in the year-ago period, it added.

For the financial year ended in March 2013, the company had posted a consolidated profit of Rs 655.30 crore as against Rs 652.59 crore in the previous fiscal.

Cadila's total consolidated income in 2012-13 was at Rs 6,395.08 crore as compared to Rs 5,314.26 crore in 2011-12.

Meanwhile, in a separate filing, Cadila said its Board of Directors has declared interim dividend of Rs 7.50 per equity share of Rs 5 each on 20,47,48,520 equity shares for the year ended on March 31, 2013.

Shares of Cadila Healthcare were trading at Rs 773 per scrip in the afternoon trade, down 1.81% from the previous close on the BSE.